HealthQuill Duality Biologics
BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer antibody drug candidates.
Drugs Medical Pharma

BioNTech, Duality Biologics sign $1.5 billion pact for cancer drugs

HQ Team April 3, 2023: BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer.

Read More
X